Bipolaris sorokiniana-Induced Black Point, Common Root Rot, and Spot Blotch Diseases of Wheat: A Review
AM Al-Sadi - Frontiers in cellular and infection microbiology, 2021 - frontiersin.org
Wheat is among the ten top and most widely grown crops in the world. Several diseases
cause losses in wheat production in different parts of the world. Bipolaris sorokiniana …
cause losses in wheat production in different parts of the world. Bipolaris sorokiniana …
An update on pharmacotherapy for leishmaniasis
S Sundar, J Chakravarty - Expert opinion on pharmacotherapy, 2015 - Taylor & Francis
Introduction: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous
leishmaniasis (CL) and mucocutaneous leishmaniasis. The treatment of leishmaniasis is …
leishmaniasis (CL) and mucocutaneous leishmaniasis. The treatment of leishmaniasis is …
Current and emerging medications for the treatment of leishmaniasis
J Chakravarty, S Sundar - Expert opinion on pharmacotherapy, 2019 - Taylor & Francis
Introduction: Leishmaniasis is a vector-borne neglected tropical disease which manifests as
visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucocutaneous …
visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucocutaneous …
Amphotericin B: A drug of choice for Visceral Leishmaniasis
Visceral leishmaniasis or Kala-azar is a vector-borne disease caused by an intracellular
parasite of the genus leishmania. In India, Amphotericin B (AmB) is a first-line medication for …
parasite of the genus leishmania. In India, Amphotericin B (AmB) is a first-line medication for …
Chemotherapeutics of visceral leishmaniasis: present and future developments
Treatment of Visceral Leishmaniasis (VL), a neglected tropical disease, is very challenging
with few treatment options. Long duration of treatment and drug toxicity further limit the target …
with few treatment options. Long duration of treatment and drug toxicity further limit the target …
Recent developments and future prospects in the treatment of visceral leishmaniasis
Limited therapeutic options in visceral leishmaniasis (VL) make the treatment of this
neglected disease very challenging. In addition to this, long treatment duration and toxic …
neglected disease very challenging. In addition to this, long treatment duration and toxic …
Leishmaniasis: treatment updates and clinical practice guidelines review
NK Copeland, NE Aronson - Current Opinion in Infectious …, 2015 - journals.lww.com
Leishmaniasis remains a neglected tropical disease, with a need for additional clinical trials
with better design and reported endpoints to lead evidence-based treatment …
with better design and reported endpoints to lead evidence-based treatment …
New insights into leishmaniasis in the immunosuppressed
H Akuffo, C Costa, J van Griensven… - PLoS neglected …, 2018 - journals.plos.org
Immunosuppression contributes significantly to the caseload of visceral leishmaniasis (VL).
HIV coinfection, solid organ transplantation, malnutrition, and helminth infections are the …
HIV coinfection, solid organ transplantation, malnutrition, and helminth infections are the …
Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence
Introduction: Visceral leishmaniasis (VL) is a fatal parasitic disease caused by a parasite
belonging to the Leishmania donovani complex and transmitted by infected female …
belonging to the Leishmania donovani complex and transmitted by infected female …
Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context
Background In the Mediterranean basin, Leishmania infantum is the causative agent of
visceral leishmaniasis (VL), a zoonosis in which the dog is the primary domestic reservoir …
visceral leishmaniasis (VL), a zoonosis in which the dog is the primary domestic reservoir …